"Centre de traitement de pointe du cancer en Sarthe. Composé d'un service de radiothérapie, d'un service de médecine nucléaire (scintigraphie) et d'une unité de recherche clinique. Le centre propose des consultations d'oncologie, d'hématologie et de radiothérapie."

During the past decade, Centre Jean Bernard conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 18 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 11 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Jean Bernard" #1 sponsor was "Weprom" with 13 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 11 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Jean Bernard" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Foundation Medicine" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Centre Jean Bernard" are "Breast Cancer" (5 trials), "Multiple Myeloma" (5 trials), "Ovarian Cancer" (5 trials), "Lung Cancer" (4 trials) and "Cancer" (3 trials). Many other conditions were trialed in "Centre Jean Bernard" in a lesser frequency.

Most popular intervention types in "Centre Jean Bernard" are "Drug" (58 trials), "Other" (16 trials), "Radiation" (7 trials), "Procedure" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "fluorouracil" (5 trials), "paclitaxel" (5 trials), "radiation therapy" (5 trials) and "Abemaciclib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centre Jean Bernard" are 56 trials for "All" genders, 13 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Jean Bernard". 1 are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Centre Jean Bernard, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Jean Bernard, 4 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".